| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |